Intravenous ketamine for chronic nonmalignant pain
Record ID 32011000804
English
Authors' objectives:
Chronic pain, or pain lasting longer than 3 months or beyond the time of expected tissue healing, is thought to affect 2% to 40% of the adult population. Chronic nonmalignant pain includes central pain, fibromyalgia, ischemic pain, neuropathic pain, orofacial pain, phantom/stump pain, postherpetic neuralgia, and complex regional pain syndrome (CRPS). CRPS is a severe chronic pain condition that most often develops following trauma. Most chronic pain disorders respond best to a combination of treatment modalities or a multidisciplinary plan including physical therapy, drug therapy, sympathetic nerve block, spinal cord stimulation, and intrathecal drug pumps to deliver opioids and local anesthetic agents via the spinal cord.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=12257
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Infusions, Intravenous
- Ketamine
- Pain
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.